Huntington National Bank Citius Pharmaceuticals, Inc. Transaction History
Huntington National Bank
- $13.8 Billion
- Q4 2024
Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
7Shares Held
2.32MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.81MShares$3.25 Million0.0% of portfolio
-
Chelsea Counsel CO281KShares$506,3400.07% of portfolio
-
Key Bridge Compliance, LLC Covington, KY154KShares$277,4340.03% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ40.3KShares$72,5090.0% of portfolio
-
Ifp Advisors, Inc33.3KShares$59,9990.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $263M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...